Trial intelligence / Profile preview

Atorvastatin Effects on Emotional Processing in Healthy Volunteers

NCT03966859Completed

Sponsor
University of Oxford
Start
Jun 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in major depressive disorder (MDD) comparing Placebo with Atorvastatin (2 arms). Primary endpoints: Accuracy during facial expression recognition task at Day 8, Reaction times during facial expression recognition task at Day 8 and 7 more. Started Jun 2019; status: completed.

02

Drugs

atorvastatin
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT03966859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03966859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call